Novel Treatment for Patients with Endocarditis


Melissa Gray reports that according to the late-breaking outcomes of the POET trial, the novel treatment plan can minimize the hospital stay for some patients with endocarditis. This study was demonstrated in a Hot Line Session at ESC Congress 2018. The latest research is available online in the New England Journal of Medicine. The Danish POET assessment studied the possibility and harmlessness of minimizing the duration of intravenous antibiotic treatment. The study also concentrated on offering outstanding antibiotics orally for some endocarditis patients.

Professor Henning Bundgaard, main investigator, Copenhagen University Hospital, Denmark, proclaimed that staying in the hospital for about 6 Weeks to avail an intravenous treatment is a huge challenge for patients. He stated that the intravenous treatment is linked to increased risk of complications. Bundgaard added that reduction in the duration of patients’ stay in hospitals has enhanced results in numerous other diseases. He assured that the use of oral antibiotics can be a secure method to reach this goal.  On a similar note, recently, scientists proclaimed that a non-invasive test might be useful in avoiding the redundant heart procedures. The latest study was presented at ESC Congress 2018. It available online in the Journal of the American College of Cardiology.